[January 10, 2017] |
|
Recombinetics Expands Its Scientific Advisory Board
Recombinetics, a leader in gene-editing of livestock for lifesaving
human therapeutics and safe and healthy food production, announces the
expansion of its Scientific Advisory Board, led by Recombinetics'
co-founder and Board Director, Dr. Perry Hackett. The advisory board
consists of renowned leaders in academia and biotechnology who will
bring valuable insights and highly-acclaimed expertise to the Company.
Recombinetics' Scientific Advisory Board now includes:
-
Perry Hackett, Ph.D. (Chair) is an inventor and preeminent
scientist with more than 50 years of experience in genetic sciences.
He is a professor and research scientist in the University of
Minnesota's Department of Genetics, Cell Biology and Development, and
co-founder of the Center for Genome Engineering. Dr. Hackett's
research success in using DNA transposons for gene-transfer led to his
co-founding of a gene therapy company, Discovery Genomics, Inc., where
he previously served as Chief Scientific Officer and Chairman.
-
Jef Boeke, Ph.D. is an expert in yeast genetics including
transposon dynamics and assembling artificial chromosomes. He is the
founding director of the Institute for Systems Genetics and a
professor in the Department of Biochemistry and Molecular Pharmacology
at the NYU Langone Medical Center. Dr. Boeke is a member of the
American Academy of Arts and Sciences and the National Academy of
Sciences.
-
Dana Carroll, Ph.D. is a pioneer in the development of
zinc-finger nucleases as gene-targeting tools and an expert in the
applications and regulation of gene-editing technologies. Dr. Carroll
is a distinguished professor in biochemistry at the University of Utah
School of Medicine and is a member of the Nuclear Control of Cell
Growth and Differentiation Program at the Huntsman Cancer Institute in
Salt Lake City. He is an awardee of the Novitski Prize from the
Genetics Society of America for establishing the field of genome
editing.
-
George Church, Ph.D. is a leader in the fields of computational
genetics, genomics, bioinformatics, systems biology, bioengineering,
and technology development. He is a professor of genetics at Harvard
Medical School and a professor of health sciences and technolgy at
Harvard and MIT (News - Alert) and a founding member of the Wyss Institute for
Biologically Inspired Engineering. Dr. Church is director of the U.S.
Department of Energy Technology Center, director of the National
Institutes of Health Center of Excellence in Genomic Science and
director of the Personal Genome Project. He has co-founded nine
biotech companies and is a member of the National Academy of Sciences
and the National Academy of Engineering.
-
Ina Dobrinski, D.V.M., Ph.D. is a pioneer in germ-line,
stem-cell biology in large animals. She is a professor of reproductive
biology and the head of the Department of Comparative Biology and
Experimental Medicine at the University of Calgary. Dr. Dobrinski is
board certified by the American College of Theriogenologists (Animal
Reproduction).
-
Stephen C. Ekker, Ph.D. is a pioneer in the use of diverse
genome engineering tools in zebrafish and other organisms. He is a
professor of biochemistry and molecular biology at the Mayo Clinic and
associate director of the Clinical and Translational Sciences Ph.D.
program. Dr. Ekker is president of the Zebrafish Disease Models
Society and editor-in-chief of the Zebrafish journal. He is
co-founder of three biotech companies and one non-profit, and the
founding director of the Center for Genome Engineering at the
University of Minnesota.
-
Lee Hood, M.D. is a leading biomedical
scientist-inventor-entrepreneur, best known for his inventions and
systems approaches that were the foundation for determining the
sequence of the human genome, and for reading and writing genomes and
polypeptides. He is co-founder and president of the Institute for
Systems Biology in Seattle, WA where he is focusing on Systems
Medicine (P4 medicine). Dr. Hood has been awarded the Lasker
Prize, Kyoto Prize, National Medal of Science, and numerous other
international awards. He is a co-founder of 13 biotechnology
companies, and is one of only 15 scientists to be a member of the
National Academy of Sciences, National Academy of Medicine, and the
National Academy of Engineering.
-
Jerry Taylor, Ph.D. is one of the top scholars and influencers
in the field of agricultural genomics. He is best known for
establishing ways to use DNA-based genomic improvement in livestock
and crops. Dr. Taylor is a professor of genetics and animal sciences
at the University of Missouri and the Wurdack Chair of Animal
Genomics. He is a founder of GenomicFX, Inc., and fellow of
the American Association for the Advancement of Science.
-
Bruce Whitelaw, Ph.D. is a pioneer in the development of
genetically engineered and genome edited livestock for biomedical and
agricultural applications. He is head of the Division of Developmental
Biology at the Roslin Institute and a professor of animal
biotechnology at the Royal (Dick) School of Veterinary Studies in
Edinburgh, Scotland. Dr. Whitelaw is the editor of Transgenic
Research, and serves on several scientific advisory boards.
About Recombinetics: Founded in 2008, RCI is widely recognized as
the global leader in livestock gene editing and applied technology for
biomedical research, regenerative medicine, and agriculture.
Delivering viable products and generating revenues today, RCI is rapidly
growing to commercialize the sale and distribution of its gene-edited
animals to the large biomedical and agricultural markets. RCI develops
precise swine models of patient congenital and progressive diseases,
including neurodegenerative diseases, heart disease, diabetes, and
cancer. RCI is also adding value to animals and the protein production
chain, accelerating the addition of genetically preferable traits that
enhance productivity while improving animal health and welfare.
Learn more at Recombinetics.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170110005835/en/
[ Back To TMCnet.com's Homepage ]
|